. Author manuscript; available in PMC: 2014 Jul 7.

Published in final edited form as: Clin Breast Cancer. 2013 Aug;13(4):254–263. doi: 10.1016/j.clbc.2013.02.010

Table 4.

Results of Logistic Regression for Long-Term vs. Short-Term Clinical Benefit

	Univariate Analysis, OR (95% CI)	P	Multivariate Analysis, OR (95% CI)	P
HR (Positive vs. Negative)	2.20 (1.02-4.75)	.045	2.39 (1.08-5.31)	.032
Age Category (50 years and older vs. younger than 50 years)	0.97 (0.45-2.08)	.937	1.06 (0.48-2.35)	.890
DFI Category (≥2 vs. <2 years)	1.04 (0.49-2.20)	.924	0.86 (0.39-1.90)	.707
Sites at Initial Metastatic Diagnosis and/or Recurrence (Continuous)	0.92 (0.68-1.26)	.612	0.83 (0.59-1.18)	.300
Visceral Involvement (Yes vs. No) ^a	1.45 (0.64-3.27)	.374	1.82 (0.74-4.49)	.193

Abbreviations: DFI = disease-free interval; HR = hormone receptor.

Visceral involvement included liver and lung.